- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04515940
Acceptability and Tolerance Study of a High Energy Peptide Based Paediatric Oral Nutritional Supplement for Children
Evaluation of the Acceptability (Including Gastrointestinal Tolerance, Compliance and Palatability) of a High Energy Peptide Based Paediatric Oral Nutritional Supplement for Children Over 12 Months of Age
This is an acceptability study (including gastrointestinal tolerance, compliance and palatability) of a high energy peptide based paediatric oral nutritional supplement for children over 12 months of age.
The acceptability data from a minimum of 15 participants will be collected in order to submit an application to the Advisory Committee on Borderline Substances (ACBS).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Fifteen (15) participants, aged 12 months and over, requiring a high energy peptide based oral nutritional supplement drink for the dietary management.
The ACBS requirement for evaluable data on 15 participants has informed the trial's recruitment target; however, we may need to exceed this target if any patients give their consent to join the study but then decide not to participate in the study. Participants who join the study and begin using the product would count towards the recruitment total and their data would be included in a submission to the ACBS whether they complete the 7-day study period or not.
Each potential participant must meet all of the inclusion criteria and not meet any of the exclusion criteria.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Sussex
-
Brighton, Sussex, United Kingdom, BN2 5BE
- Nutrition and Dietetics
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
I. Children aged 1 year and over who require 1-3 bottles of an oral nutritional peptide based supplement drink II. Children who require an oral nutritional supplement or who are already established on a nutritional supplement drink III. Children who require a nutritional supplement drink as bolus feeding via a feeding tube.
IV. Children being able to communicate views of acceptability V. Willingly given, written, informed consent from patient or parent/guardian. VI. Willingly given, written assent (if appropriate).
Exclusion Criteria:
I. Inability to comply with the study protocol, in the opinion of the investigator.
II. Contraindications to any feed ingredients (see nutritional table and ingredients list) III. Require a milk free diet IV. Children under the age of 12 months V. Emergencies
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gastrointestinal tolerance
Time Frame: Day 7 from baseline
|
Daily record via participant diary:
Questionnaires to children and or parents for the evaluation of the acceptability and ease of use of the milk supplement drink Diarrhoea, constipation, bloating, distension, nausea, vomitting, burping, abdominal pain |
Day 7 from baseline
|
Compliance
Time Frame: Day 7 from baseline
|
volume suggested versus consumed
|
Day 7 from baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
weight in kg
Time Frame: Day 8 from baseline
|
At baseline
|
Day 8 from baseline
|
height in meters
Time Frame: Day 8 from baseline
|
At basline
|
Day 8 from baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Chris Smith, Nutrition and Dietetics
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ONS peptide 1.5
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nutrition Disorder, Child
-
Universidad de MonterreyFEMSA FoundationCompletedMalnutrition | Malnutrition, Child | Malnutrition in Children | Child Malnutrition | Child Overnutrition | Nutrition Disorders, Child
-
Universidad de MonterreyFEMSA Foundation; Mexican Food BanksCompletedMalnutrition | Malnutrition, Child | Malnutrition in Children | Child Malnutrition | Child Overnutrition | Nutrition Disorders, ChildMexico
-
Alexandria UniversityCompletedNeurologic Disorder | Nutrition Disorder, ChildEgypt
-
Assiut UniversityNot yet recruitingNutrition Disorder, Child
-
NestléWithdrawnEnteral Feeding Intolerance | Tube Feeding | Nutrition Disorder, ChildUnited States
-
Boston Children's HospitalWellcome Trust; International Centre for Diarrhoeal Disease Research, Bangladesh and other collaboratorsRecruitingEmotional Regulation | Malnutrition, Child | Executive Function DisorderBangladesh
-
Shanghai Jiao Tong University School of MedicineCompleted
-
Turku University HospitalUniversity of TurkuUnknownOverweight | Weight Change, Body | Nutrition Disorder, ChildFinland
-
Assiut UniversityRecruiting
-
Shenzhen Center for Chronic Disease ControlSun Yat-sen UniversityCompletedGrowth Disorders | Nutritional and Metabolic Diseases | Nutrition, Healthy | Development, Child | Nutritional Deficiency | Development, Adolescent | Nutrition Disorder, Child | Nutritional Stunting | Growth; Stunting, Nutritional | Nutritional Imbalance | Nutrition Disorders in AdolescenceChina
Clinical Trials on acceptability, tolerance and palatability study
-
Société des Produits Nestlé (SPN)TerminatedInfant DevelopmentUnited Kingdom
-
University of Sao PauloCompleted
-
UfoniaBuckinghamshire Healthcare NHS Trust; Innovate UKNot yet recruitingCataract After
-
American University of Beirut Medical CenterCompletedEating Behavior
-
American University of Beirut Medical CenterCompleted
-
Puerto Rico Community Network for Clinical Research...Gilead SciencesUnknown
-
University of VirginiaCompleted
-
University of CincinnatiCompletedHPV Vaccine AcceptabilityUnited States
-
Klein Buendel, Inc.University of Oregon; Eunice Kennedy Shriver National Institute of Child Health... and other collaboratorsCompletedEmotional Regulation | Adolescent Behavior | Risky Sexual BehaviorUnited States
-
Centre de santé sexuelle Le 190Pitié-Salpêtrière HospitalRecruiting